|
Antibiotic
|
Antibiotic susceptibilitya(%)
|
|---|
| |
E. coli
|
All Gram -
|
All Gram +
|
All pathogens
|
|---|
|
(n = 157)
|
(n = 178)
|
(n = 25)
|
(n = 203)
|
|---|
|
Amoxicillin
|
63
|
56
|
32
|
/
|
|
Amox/clav
|
91
|
88
|
NTb
|
/
|
|
Ticarcillin
|
64
|
61
|
NT
|
/
|
|
Ticar/clav
|
92
|
92
|
NT
|
/
|
|
Piperacillin
|
64
|
61
|
NT
|
/
|
|
Pip/Taz
|
99
|
99
|
NT
|
/
|
|
Pivmecillinam
|
87
|
88
|
NT
|
76c
|
|
Cefalotin
|
63
|
61
|
NT
|
/
|
|
Cefotaxime
|
99
|
99
|
NT
|
/
|
|
Ceftazidime
|
99
|
99
|
NT
|
/
|
|
Cefepime
|
99
|
99
|
NT
|
/
|
|
Imipenem/cilastatin
|
100
|
100
|
NT
|
/
|
|
Gentamicin
|
99
|
99
|
57d
|
/
|
|
Tobramycin
|
99
|
99
|
NT
|
/
|
|
Amikacin
|
100
|
100
|
NT
|
/
|
|
Netilmicin
|
99
|
99
|
NT
|
/
|
|
TMP-SMX
|
87
|
87
|
63
|
85
|
|
Nalidix acid
|
97
|
87
|
NT
|
/
|
|
Ofloxacin
|
97
|
99
|
59
|
94
|
|
Levofloxacin
|
97
|
99
|
95
|
98
|
|
Nitrofurantoin
|
100
|
92e
|
100
|
98
|
|
Fosfomycin
|
99
|
98
|
27
|
89
|
|
Fucidic acid
|
NT
|
NT
|
58
|
/
|
|
Erythromycin
|
NT
|
NT
|
17
|
/
|
|
Lincomycin
|
NT
|
NT
|
62
|
/
|
|
Pristinamycin
|
NT
|
NT
|
62
|
/
|
|
Rifampin
|
NT
|
NT
|
61
|
/
|
|
Vancomycin
|
NT
|
NT
|
100
|
/
|
-
aIntermediate strains considered resistant.
-
bNT: not tested.
-
cAll Gram + were considered resistant in vitro to pivmecillinam.
-
dNatural low level resistance of Streptococcus and Enterococcus spp considered non susceptible.
-
e
Proteus spp considered naturally resistant to nitrofurantoin.
